• 互联网药品信息服务资格证书
    证书编号:(粤)-非经营性-2021-0182

  • 营业执照
    证书编号:91440101MA9XNDLX8Q

药直供 > 健康问答 > 爱博新国内多少钱

问题爱博新国内多少钱

爱博新国内多少钱

好问题 122
分享
浏览量 1388
提问时间: 2025-05-04 17:54:24
回答

爱博新国内多少钱,爱博新(Palbociclib)的版本有:1、印度卢修斯版本;2、老挝贝泉生物版本;3、美国辉瑞版本;4、孟加拉耀品国际版本;5、孟加拉碧康制药版本;6、孟加拉伊思达版本;代购价格是850元左右,不同版本价格不同,以实际为准。请选择正规海外代购渠道,以保证产品质量。

爱博新(Palbociclib):一种用于乳腺癌治疗的创新药物

乳腺癌是一种常见的女性恶性肿瘤,也可罹患于男性。随着医疗技术的不断进步,人们对于乳腺癌的治疗也有了新的突破。爱博新(Palbociclib)是一种新型的药物,广受医学界和患者的关注。本文将对爱博新的功效、使用方法以及价格进行介绍。

1. 爱博新的功效

爱博新属于一类称为CDK4/6抑制剂的药物,能够干扰癌细胞的增殖过程,从而抑制乳腺癌的生长和扩散。通过作用于细胞周期蛋白依赖性激酶4和激酶6,爱博新能有效延长乳腺癌患者的生存期,并提高治疗效果。这一创新药物为那些存在激素受体阳性和HER2阴性的晚期或转移性乳腺癌患者提供了新的希望。

2. 使用方法

使用爱博新需要严格按照医生的指导和处方药规定。通常,爱博新以口服药物的形式供应,每日一次,连续21天,随后休药7天,形成28天一个疗程。在服药期间,患者通常要定期进行血液检查和其他相关检查,以便医生监测治疗的效果和可能的副作用。

3. 价格信息

爱博新是一种创新抗癌药物,其价格相对较高。根据厂家和疗程需求不同,爱博新在国内的价格通常在人民币数万元到数十万元之间。具体的价格可能因病情、地理位置、医疗机构等因素而有所变化。患者在选择治疗方案时,应充分考虑自身经济实力,并咨询医生以获取更准确的价格信息。

4. 结语

爱博新作为一种新型的乳腺癌治疗药物,为患者提供了新的希望。它的应用可帮助患者延长生存期,并改善治疗效果。由于其较高的价格,患者在选择时需要全面考虑自身情况和财务能力。同时,我们也期待未来科技的进步,希望能够降低创新药物的价格,让更多的患者能够受益于现代医学的进展。

【参考译文】

Palbociclib (爱博新): An Innovative Medication for Breast Cancer Treatment

Breast cancer is a commonly occurring malignant tumor in women, and it can also affect men. With the continuous advancement of medical technology, there have been new breakthroughs in the treatment of breast cancer. Palbociclib, an innovative drug, has gained considerable attention from the medical community and patients. In this article, we will introduce the efficacy, usage, and price of Palbociclib.

1. Efficacy of Palbociclib

Palbociclib belongs to a class of drugs called CDK4/6 inhibitors, which can interfere with the proliferation process of cancer cells, thereby inhibiting the growth and spread of breast cancer. By acting on cyclin-dependent kinases 4 and 6, Palbociclib effectively prolongs the survival of breast cancer patients and improves treatment outcomes. This innovative drug offers new hope for patients with hormone receptor-positive and HER2-negative advanced or metastatic breast cancer.

2. Usage of Palbociclib

The use of Palbociclib should strictly follow the doctor's guidance and prescription. Typically, Palbociclib is supplied in oral form, taken once daily for 21 consecutive days, followed by a 7-day break, forming a 28-day treatment cycle. During the treatment, patients are usually required to undergo regular blood tests and other relevant examinations to monitor the treatment's effectiveness and potential side effects.

3. Price Information

Palbociclib is an innovative anti-cancer drug with a relatively high price. Depending on the manufacturer and treatment requirements, the price of Palbociclib in China generally ranges from tens of thousands to several hundred thousand RMB. However, the specific price may vary due to factors such as the patient's condition, geographical location, and medical institutions. When choosing a treatment plan, patients should consider their own financial capabilities and consult with their doctor to obtain more accurate price information.

4. Conclusion

As a novel breast cancer treatment drug, Palbociclib provides new hope for patients. Its application can help patients prolong their survival and improve treatment outcomes. However, due to its high price, patients need to fully consider their own circumstances and financial resources when making choices. At the same time, we look forward to future technological advancements and hope that the prices of innovative drugs can be reduced, so that more patients can benefit from the progress of modern medicine.

24小时药师咨询 哌柏西利的相关介绍
注:本站所有内容仅供参考,不代表药直供立场(如有错漏,请帮忙指正),转载请注明出处。不作为诊断及治疗依据,不可替代专业医师诊断、不可替代医师处方。本站不承担由此导致的相关责任!
  • 帕博西尼基本信息

    帕博西尼
    • 剂型:

      片剂

    • 厂家:

      印度卢修斯

    • 适应症:

      治疗晚期转移性乳腺癌,显著延长中位无进展生存期

  • 帕博西尼基本信息

    帕博西尼
    • 剂型:

      片剂

    • 厂家:

      孟加拉伊思达

    • 适应症:

      治疗晚期转移性乳腺癌,显著延长中位无进展生存期

  • 帕博西尼基本信息

    帕博西尼
    • 剂型:

      片剂

    • 厂家:

      孟加拉碧康制药

    • 适应症:

      治疗晚期转移性乳腺癌,显著延长中位无进展生存期

  • 帕博西尼基本信息

    帕博西尼
    • 剂型:

      片剂

    • 厂家:

      孟加拉耀品国际

    • 适应症:

      治疗晚期转移性乳腺癌,显著延长中位无进展生存期

  • 帕博西尼 Palbociclib Parcini基本信息

    帕博西尼 Palbociclib Parcini
    • 剂型:

      胶囊

    • 厂家:

      老挝东盟制药

    • 适应症:

      治疗晚期转移性乳腺癌,显著延长中位无进展生存期

回答时间:2025-05-04 17:59:12

特别声明:本站内容仅供参考,不作为诊断及医疗依据。本网站不销售任何药品,只做药品信息资讯展示!

不良信息举报邮箱:zsex@foxmail.com  版权所有 Copyright©2023 www.yzgmall.com All rights reserved

互联网药品信息服务资格证书编号:(粤)-非经营性-2021-0182    |   粤ICP备2021070247号 |   药直供手机端 |   网站地图